Building Blocks for Pharmaceutical Ingredients (for Research and Experimental Use)
COUNTRY OF ORIGIN
Japan
APPLICATION
A Synthetic Intermediate of Suvorexant (MK-4305)
This product is used for the synthesis of suvorexant (MK-4305) which is a dual orexin receptor antagonist (DORA) used for the treatment of insomnia.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P302 + P352 : IF ON SKIN: Wash with plenty of soap and water.
P332 + P313 : If skin irritation occurs: Get medical advice/ attention.
P362 : Take off contaminated clothing and wash before reuse.
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
PURITY
>98.0%(T)(HPLC)
PHYSICAL FORM
Solid
MWCO (kDa)
203.20
QUALITY CERTIFICATION / COMPLIANCE
Fukaya factory is certified for GMP, ISO14001:2004 (JQA-EM5386) and IQ Net (JP-JQA-EM5386).
APPEARANCE
White to Light yellow powder to crystal
MOLECULAR FORMULA
C10H9N3O2
PURITY (HPLC)
min. 98.0 area%
HS NUMBER
2933.99.8290
PURITY / ANALYSIS METHOD
>98.0%(T)(HPLC)
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Ambient
Safety & Storage
Storage Temperature
See product label for specific storage conditions.
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.